GlassScriptPhysician profile
Abby M Thames
NPI 1780086249
$1,880.99
in general payments reported to CMS, 2019-2025
28 companies · $405 in 2025
The $405 reported for 2025 was more than what 76% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $387 · 2022: $339 · 2023: $412 · 2024: $338 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.66 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $411.85 | 2021-2025 | |
| Astellas Pharma US INC | $307.35 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $121.03 | 2023-2024 | Gemtesa |
| Janssen Biotech, INC. | $118.39 | 2024-2025 | Erleada, Akeega |
| Allergan, INC. | $87.00 | 2021 | |
| Endo Pharmaceuticals INC. | $78.31 | 2021-2024 | Aveed, Xiaflex, Edex |
| Pfizer INC. | $68.57 | 2025 | |
| Procept Biorobotics Corporation | $66.51 | 2022-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $62.59 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $59.13 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $48.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $46.72 | 2023-2025 | |
| Teleflex LLC | $45.27 | 2024 | Urolift |
| Hollister Incorporated | $43.65 | 2022-2023 | Infyna Chic |
| Merck Sharp & Dohme LLC | $38.38 | 2022-2023 | Lynparza, Keytruda |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $34.52 | 2021-2022 | |
| Olympus America INC. | $28.44 | 2025 | Itind System |
| Photocure INC | $28.12 | 2022-2023 | Cysview |
| Abc Home Medical Supply, INC. | $25.57 | 2023 | |
| Coloplast Corp | $24.47 | 2023 | Speedicath |
| Tolmar, INC. | $21.76 | 2024 | |
| Sagent Pharmaceuticals | $20.91 | 2025 | Glydo |
| Cycle Pharmaceuticals INC | $17.62 | 2025 | Venxxiva |
| 180 Medical, INC. | $16.48 | 2021 | |
| Boston Scientific Corporation | $16.15 | 2022 | |
| Axonics, INC. | $15.32 | 2022 | |
| Ethicon US, LLC | $15.00 | 2023 | Vistaseal, Stratafix |
| Ferring Pharmaceuticals INC. | $13.70 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Thames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.